- Home
- KROS vs WLDN Comparison
KROS vs WLDN Comparison
Compare KROS & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- WLDN
- Stock Information
- Founded
- KROS 2015
- WLDN 1964
- Country
- KROS United States
- WLDN United States
- Employees
- KROS N/A
- WLDN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- WLDN Military/Government/Technical
- Sector
- KROS Health Care
- WLDN Consumer Discretionary
- Exchange
- KROS Nasdaq
- WLDN Nasdaq
- Market Cap
- KROS 589.8M
- WLDN 581.0M
- IPO Year
- KROS 2020
- WLDN 2006
- Fundamental
- Price
- KROS $11.49
- WLDN $38.23
- Analyst Decision
- KROS Buy
- WLDN Strong Buy
- Analyst Count
- KROS 11
- WLDN 3
- Target Price
- KROS $45.33
- WLDN $44.33
- AVG Volume (30 Days)
- KROS 1.9M
- WLDN 114.9K
- Earning Date
- KROS 02-26-2025
- WLDN 03-06-2025
- Dividend Yield
- KROS N/A
- WLDN N/A
- EPS Growth
- KROS N/A
- WLDN 802.09
- EPS
- KROS N/A
- WLDN 1.63
- Revenue
- KROS $651,000.00
- WLDN $577,414,000.00
- Revenue This Year
- KROS $303.27
- WLDN N/A
- Revenue Next Year
- KROS N/A
- WLDN $7.28
- P/E Ratio
- KROS N/A
- WLDN $23.78
- Revenue Growth
- KROS 8037.50
- WLDN 23.47
- 52 Week Low
- KROS $9.78
- WLDN $18.37
- 52 Week High
- KROS $73.00
- WLDN $50.00
- Technical
- Relative Strength Index (RSI)
- KROS 22.41
- WLDN 46.80
- Support Level
- KROS $9.78
- WLDN $34.73
- Resistance Level
- KROS $11.63
- WLDN $39.09
- Average True Range (ATR)
- KROS 0.86
- WLDN 1.12
- MACD
- KROS 1.15
- WLDN 0.33
- Stochastic Oscillator
- KROS 23.32
- WLDN 79.55
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.